1.87MMarket Cap
LossP/E TTM
Iterum Therapeutics PLC's Company Valuation
Currency: USD Updated: 2026-03-31The current valuation score of Iterum Therapeutics PLC is 7.65, ranking 93 out of 391 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.04, which is -100.00% below the recent high of 0.00 and -3675.54% above the recent low of -1.57.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.